Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Strides Pharma Science LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532531NSE Symbol: STARP/E(TTM):94.07
ISIN Demat:INE939A01011Div & Yield %:0.16EPS(TTM):9.53
Book Value(Rs):376.844232Market Cap ( Cr.):8238.35Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 1854.501979.001857.571691.931537.441469.61
Excise Duty0.000.000.000.000.000.00
Net Sales1854.501979.001857.571691.931537.441469.61
Other Income 84.07123.49117.0993.07114.61894.95
Stock Adjustments -21.04-114.26117.532.8845.5217.79
Total Income1917.531988.232092.191787.881697.572382.35
EXPENDITURE :      
Raw Materials 1044.57987.261106.41894.84924.35799.04
Power & Fuel Cost45.5443.7645.8244.5339.7733.08
Employee Cost 267.01272.09272.72230.23223.21224.54
Other Manufacturing Expenses 130.03151.87134.86117.4376.0094.37
Selling and Administration Expenses 182.64260.83171.51117.95132.91118.12
Miscellaneous Expenses 80.1972.3184.5685.3755.2454.16
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1749.981788.121815.871490.351451.481323.30
Operating Profit167.54200.11276.32297.53246.081059.05
Interest 138.6874.2465.3466.8454.0981.97
Gross Profit28.86125.87210.98230.69191.99977.08
Depreciation93.62104.3799.3494.2483.0077.81
Profit Before Tax-64.7621.50111.64136.45108.99899.27
Tax-49.84-169.6633.6518.760.5837.32
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-19.6010.98-0.26-2.59-1.96-29.64
Reported Net Profit4.68180.1978.24120.28110.37891.59
Extraordinary Items -16.324.233.263.413.86-29.94
Adjusted Net Profit21.00175.9674.98116.87106.51921.53
Adjst. below Net Profit 0.000.000.00-57.25-9.30-711.39
P & L Balance brought forward740.89583.13522.80616.08532.93393.00
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.0022.4317.91156.3017.9140.27
P & L Balance carried down745.57740.89583.13522.80616.08532.93
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %15.000.0025.00140.0030.0020.00
Earnings Per Share-Unit Curr0.5220.078.7213.4312.3299.62
Earnings Per Share(Adj)-Unit Curr0.5220.078.7213.4312.3296.41
Book Value-Unit Curr382.61379.36362.18352.68363.69353.28